Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and PER®. Global is accredited by ACCME to provide continuing medical education for physicians.
*This CME/CE activity complies with all requirements of the federal Physician Payments Sunshine Act. If a reportable event is associated with this activity, the accredited provider managing the program will provide the appropriate physician data to the Open Payments database.
Physician Credit Designation
This educational activity will include a multidisciplinary panel consisting of a dermatologist, a rheumatologist, a family practice physician, and a patient with psoriasis. The program will define the unique aspects of care that practitioners provide to patients with psoriasis, including facilitating conversations about managing disease, setting expectations, and selecting treatment options, including when treatment response or tolerability is suboptimal. The importance of relationship building also will be explored. Practical strategies to address patient barriers, including lack of knowledge about psoriasis, fear of injections, and adverse effect risks will be provided. By engaging patients in their psoriasis care plans, family physicians can optimize outcomes and manage psoriasis and its comorbidities. Participants will be able to select which patient cases are reviewed.
Arthur M. Mandelin, MD, PhD
Assistant Professor of Medicine (Rheumatology)
Northwestern University Feinberg School of Medicine
Paul Doghramji, MD
Family Practice Physician
Collegeville Family Practice
Psoriasis Patient Advocate
Jashin J. Wu, MD, FAAD
Director of Dermatology Research
Kaiser Permanente Los Angeles Medical Center
Los Angeles, CA
ASH: Addressing Post-Transplant Obstacles: Current and Emerging Strategies to Evolve the Standard of Care for Patients with GvHD
December 8, 2017
ASH: Evaluating the Emerging Role of Biosimilar Agents for the Treatment of Hematologic Malignancies
December 8, 2017
Addressing Challenges and Personalizing Care in Postsurgical Pain Management - Brunch With the Experts
Dec 29, 2017